United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 17, 2026 · Filed Jun 18, 2026

On Jun 17, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$552.40 for US$5.25M under a trading plan, leaving 40,513 shares. Filed Jun 18, 2026 (Form 4).

Sold
9,500 shares
Price
US$552.40 average (US$548.57 to US$555.63)
Value
US$5.25M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 17, 2026Common StockSale560US$548.5749,453Direct
Jun 17, 2026Common StockSale612US$549.5748,841Direct
Jun 17, 2026Common StockSale2,077US$550.8746,764Direct
Jun 17, 2026Common StockSale1,840US$551.7344,924Direct
Jun 17, 2026Common StockSale727US$552.7544,197Direct
Jun 17, 2026Common StockSale1,201US$553.7842,996Direct
Jun 17, 2026Common StockSale1,909US$554.7741,087Direct
Jun 17, 2026Common StockSale574US$555.6340,513Direct

Source

View original at SEC

Related